Matinas BioPharma Holdings Inc (MTNB) is around the top of the Biotechnology industry according to InvestorsObserver. MTNB received an overall rating of 79, which means that it scores higher than 79 percent of all stocks. Matinas BioPharma Holdings Inc also achieved a score of 95 in the Biotechnology industry, putting it above 95 percent of Biotechnology stocks. Biotechnology is ranked 26 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Matinas BioPharma Holdings Inc Stock Today?
Matinas BioPharma Holdings Inc (MTNB) stock has fallen -6.69% while the S&P 500 has risen 0.33% as of 3:17 PM on Friday, Jan 8. MTNB has fallen -$0.11 from the previous closing price of $1.57 on volume of 5,656,629 shares. Over the past year the S&P 500 is up 16.55% while MTNB has fallen -23.04%. MTNB lost -$0.12 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Matinas BioPharma Holdings Inc (MTNB) Stock.
